GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

August 12, 2021
4:25 am

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Business Wire, Global

Share this article

dividend visibility and analyst targets in focus

May 21, 2026

Europe’s crypto stress test starts with access and portability

May 21, 2026

PARITY Act pushes new US crypto tax relief framework

May 21, 2026

The crypto market is creeping upwards across the board

May 21, 2026

AI agents help uncover crypto crime

May 21, 2026

A crypto whale has made a $224,000 bet that XRP’s price stays perfectly flat through June

May 21, 2026

How Savvy Travelers Are Using Crypto to Fund Their Entertainment Abroad

May 21, 2026

Tracking Digital Asset Markets Beyond Crypto-Native Venues

May 21, 2026